Rules Based Medicine to Pay Luminex $12.5M to Settle Lawsuit | GenomeWeb
NEW YORK (GenomeWeb News) — Rules Based Medicine will pay Luminex $12.5 million to settle a law suit having to do with Biophysical Corporation’s testing services, Luminex said today.
 
RBM, which was spun off from Luminex in September 2002, initially filed the claims in a Travis County, Texas District Court in 2005, but Luminex soon afterward responded with its own counterclaims.
  

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.